Regular, low-dose, sustained-release morphine for persisting breathlessness in interstitial lung disease: a randomised, double-blind, placebo-controlled, crossover trial.

Ferreira, DH; Ekström, M; Bajwah, S; Fazekas, B; Currow, DC

Regular, low-dose, sustained-release morphine for persisting breathlessness in interstitial lung disease: a randomised, double-blind, placebo-controlled, crossover trial.

Ferreira, DH Ekström, M Bajwah, S Fazekas, B Currow, DC

Permalink

Publisher:: EUROPEAN RESPIRATORY SOC JOURNALS LTD
Publication Type:: Journal Article
Citation:: Eur Respir J, 2023, 62, (3), pp. 2300702
Issue Date:: 2023-09

Closed Access

	Filename	Description	Size
	21842316_12582607850005671.pdf		237.19 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Ferreira, DH
dc.contributor.author	Ekström, M
dc.contributor.author	Bajwah, S
dc.contributor.author	Fazekas, B
dc.contributor.author	Currow, DC
dc.date.accessioned	2024-01-10T01:14:12Z
dc.date.available	2023-08-20
dc.date.available	2024-01-10T01:14:12Z
dc.date.issued	2023-09
dc.identifier.citation	Eur Respir J, 2023, 62, (3), pp. 2300702
dc.identifier.issn	0903-1936
dc.identifier.issn	1399-3003
dc.identifier.uri	http://hdl.handle.net/10453/174180
dc.format	Electronic-Print
dc.language	eng
dc.publisher	EUROPEAN RESPIRATORY SOC JOURNALS LTD
dc.relation.ispartof	Eur Respir J
dc.relation.isbasedon	10.1183/13993003.00702-2023
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	11 Medical and Health Sciences, 1116 Medical Physiology
dc.subject.classification	Respiratory System
dc.subject.classification	3201 Cardiovascular medicine and haematology
dc.subject.mesh	Humans
dc.subject.mesh	Morphine
dc.subject.mesh	Delayed-Action Preparations
dc.subject.mesh	Cross-Over Studies
dc.subject.mesh	Dyspnea
dc.subject.mesh	Double-Blind Method
dc.subject.mesh	Lung Diseases, Interstitial
dc.subject.mesh	Treatment Outcome
dc.subject.mesh	Humans
dc.subject.mesh	Lung Diseases, Interstitial
dc.subject.mesh	Dyspnea
dc.subject.mesh	Morphine
dc.subject.mesh	Delayed-Action Preparations
dc.subject.mesh	Treatment Outcome
dc.subject.mesh	Cross-Over Studies
dc.subject.mesh	Double-Blind Method
dc.subject.mesh	Humans
dc.subject.mesh	Morphine
dc.subject.mesh	Delayed-Action Preparations
dc.subject.mesh	Cross-Over Studies
dc.subject.mesh	Dyspnea
dc.subject.mesh	Double-Blind Method
dc.subject.mesh	Lung Diseases, Interstitial
dc.subject.mesh	Treatment Outcome
dc.title	Regular, low-dose, sustained-release morphine for persisting breathlessness in interstitial lung disease: a randomised, double-blind, placebo-controlled, crossover trial.
dc.type	Journal Article
utslib.citation.volume	62
utslib.location.activity	England
utslib.for	11 Medical and Health Sciences
utslib.for	1116 Medical Physiology
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
utslib.copyright.status	closed_access	*
dc.date.updated	2024-01-10T01:14:10Z
pubs.issue	3
pubs.publication-status	Published online
pubs.volume	62
utslib.citation.issue	3

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/174180